These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 4509641)

  • 1. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.
    Hobson D; Curry RL; Beare AS; Ward-Gardner A
    J Hyg (Lond); 1972 Dec; 70(4):767-77. PubMed ID: 4509641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum HI antibody and protection against influenza: a follow-up survey at community level of three epidemics caused by different H3N2-variants.
    Pyhälä R; Aho K
    Int J Epidemiol; 1975 Jun; 4(2):127-9. PubMed ID: 1165150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.
    Slepushkin AN; Schild GC; Beare AS; Chinn S; Tyrrell DA
    J Hyg (Lond); 1971 Dec; 69(4):571-8. PubMed ID: 5002644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified dose-response model that describes the relationship between haemagglutination inhibition titre and protection against influenza infection.
    Huang Y; Anderson SA; Forshee RA; Yang H
    J Appl Microbiol; 2018 Jan; 124(1):294-301. PubMed ID: 29112316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68.
    Machin SJ; Potter CW; Oxford JS
    J Hyg (Lond); 1970 Sep; 68(3):497-504. PubMed ID: 5272348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2).
    Larson HE; Tyrrell DA; Bowker CH; Potter CW; Schild GC
    J Hyg (Lond); 1978 Apr; 80(2):243-8. PubMed ID: 632564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis.
    Al-Khayatt R; Jennings R; Potter CW
    J Hyg (Lond); 1984 Oct; 93(2):301-12. PubMed ID: 6389697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly.
    de Bruijn IA; Remarque EJ; Beyer WE; le Cessie S; Masurel N; Ligthart GJ
    Vaccine; 1997; 15(12-13):1323-9. PubMed ID: 9302738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
    J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between haemagglutination inhibition titre and immunity to influenza in ferrets.
    Wikramaratna PS; Rambaut A
    Vaccine; 2015 Oct; 33(41):5380-5385. PubMed ID: 26342848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of haemagglutination-inhibition and single radial haemolysis techniques for detecting antibodies to influenza A and B viruses.
    Mancini G; Donatelli I; Arangio-Ruiz G; Rozera C; Macchia T
    J Hyg (Lond); 1983 Aug; 91(1):157-62. PubMed ID: 6350442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.
    Potter CW; Jennings R; McLaren C; Edey D; Stuart-Harris CH; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):353-62. PubMed ID: 1059705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WRL 105 strain (H3N2) live attenuated influenza vaccine: acceptability, reactivity, and antibody response in normal, bronchitic, and geriatric volunteers.
    Nicholson KG; Tyrrell DA; Freestone DS
    Lancet; 1976 Jun; 1(7973):1309-11. PubMed ID: 58306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.